Physician profile
Shalin Patel
NPI 1982920963
$3,095.63
in general payments reported to CMS, 2019-2025
14 companies · $88.47 in 2025
The $88.47 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,830 · 2020: $221 · 2021: $201 · 2023: $150 · 2024: $605 · 2025: $88.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,192.39 | 2019-2020 | |
| Abiomed | $653.63 | 2023-2024 | Impella |
| Boston Scientific Corporation | $263.20 | 2019-2025 | Watchman Access System |
| Abbott Laboratories | $224.15 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.02 | 2019-2021 | |
| Penumbra, INC. | $140.39 | 2019-2024 | Ruby Coil |
| Edwards Lifesciences Corporation | $117.65 | 2020 | |
| Amgen INC. | $82.03 | 2019-2023 | Repatha |
| Lantheus Medical Imaging, INC. | $73.61 | 2019 | |
| Heartflow, INC. | $43.66 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $28.90 | 2025 | |
| Medtronic, INC. | $27.50 | 2021 | |
| Pfizer INC. | $20.38 | 2024 | |
| Novo Nordisk INC | $20.12 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.